Abstract
Objective
Pulmonary hypertension (PH) is associated with bronchopulmonary dysplasia (BPD). Screening strategies, a thorough investigation of co-morbidities, and multidisciplinary involvement prior to anti-PH medications have been advocated by recent guidelines. We sought to evaluate current practices of neonatologists caring for premature infants with PH.
Design
Electronic survey of American Academy of Pediatrics neonatology members.
Results
Among 306 neonatologist respondents, 38% had an institutional screening protocol for patients with BPD; 83% screened at 36 weeks for premature neonates on oxygen/mechanical ventilation. In those practicing more than 5 years, 54% noted increasing numbers of premature infants diagnosed with PH. Evaluation for PH in BPD patients included evaluations for micro-aspiration (41%), airways anomalies (29%), and catheterization (10%). Some degree of acquired pulmonary vein stenosis was encountered in 47%. A majority (90%) utilized anti-PH medications during the neonatal hospitalization.
Conclusions
Screening for PH in BPD, and subsequent evaluation and management is highly variable.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Osterman MJ, Kochanek KD, MacDorman MF, Strobino DM, Guyer B. Annual summary of vital statistics: 2012–2013. Pediatrics. 2015;135:1115–25.
Mourani PM, Sontag MK, Younoszai A, Miller JI, Kinsella JP, Baker CD, et al. Early pulmonary vascular disease in preterm infants at risk for bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2015;191:87–95.
Subhedar N, Shaw N. Changes in pulmonary arterial pressure in preterm infants with chronic lung disease. Arch Dis Child Fetal Neonatal Ed. 2000;82:F243–F247.
Mourani PM, Abman SH. Pulmonary vascular disease in bronchopulmonary dysplasia: pulmonary hypertension and beyond. Curr Opin Pediatr. 2013;25:329–37.
Khemani E, McElhinney DB, Rhein L, Andrade O, Lacro RV, Thomas KC, et al. Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era. Pediatrics. 2007;120: 1260–9.
Mourani PM, Sontag MK, Younoszai A, Ivy DD, Abman SH. Clinical utility of echocardiography for the diagnosis and management of pulmonary vascular disease in young children with chronic lung disease. Pediatrics. 2008;121:317–25.
Altit G, Dancea A, Renaud C, Perreault T, Lands LC, Sant’Anna G. Pathophysiology, screening and diagnosis of pulmonary hypertension in infants with bronchopulmonary dysplasia-a review of the literature. Paediatr Respir Rev. 2016;23:16–26.
Wright T, Filbrun A, Bryner B, Mychaliska G. Predictors of early lung function in patients with congenital diaphragmatic hernia. J Pediatr Surg. 2014;49:882–5.
Bhat R, Salas AA, Foster C, Carlo WA, Ambalavanan N. Prospective analysis of pulmonary hypertension in extremely low birth weight infants. Pediatrics. 2012;129:e682–e689.
Weismann CG, Montgomery AM, Asnes JD, Bazzy-Asaad A, Tolomeo C, Ehrenkranz RA, et al. Prospective Echocardiographic and Biochemical Screening for Pulmonary Hypertension in Infants with Bronchopulmonary Dysplasia. Paper presented at: UCSF 9th International Conference Neonatal & Childhood Pulmonary Vascular Disease 2016 2016.
Abman SH, Hansmann G, Archer SL, Ivy DD, Adatia I, Chung WK, et al. Pediatric pulmonary hypertension guidelines from the american heart association and american thoracic society. Circulation. 2015;132:2037–99.
An HS, Bae EJ, Kim GB, Kwon BS, Beak JS, Kim EK, et al. Pulmonary hypertension in preterm infants with bronchopulmonary dysplasia. Korean Circ J. 2010;40:131–6.
Abman SH. Pulmonary Hypertension in Bronchopulmonary Dysplasia. Respiratory Outcomes in Preterm Infants. Springer, 2017, pp 197-213. DOI https://doi.org/10.1007/978-3-319-48835-6_12. Online ISBN 978-3-319-48835-6.
Latson LA, Prieto LR. Congenital and acquired pulmonary vein stenosis. Circulation. 2007;115:103–8.
Amin R, Kwon S, Moayedi Y, Sweezey N, Pulmonary vein stenosis: case report and literature review. Can Respir J. 2009;16:e77–e80.
Edwards J. Congenital stenosis of pulmonary veins. Pathologic and developmental considerations. Lab Invest. 1959;9:46–66.
Laux D, Rocchisani MA, Boudjemline Y, Gouton M, Bonnet D, Ovaert C. Pulmonary hypertension in the preterm infant with chronic lung disease can be caused by pulmonary vein stenosis: a must-know entity. Pediatr Cardiol. 2016;37:313–21.
Swier NL, Richards B, Cua CL, Lynch SK, Yin H, Nelin LD, et al. Pulmonary vein stenosis in neonates with severe bronchopulmonary dysplasia. Am J Perinatol. 2016;33:671–7.
Mahgoub L, Kaddoura T, Kameny AR, Lopez Ortego P, Vanderlaan RD, Kakadekar A, et al. Pulmonary vein stenosis of ex‐premature infants with pulmonary hypertension and bronchopulmonary dysplasia, epidemiology, and survival from a multicenter cohort. Pediatr Pulmonol. 2017;52:1063–70.
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377–81.
Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;163:1723–9.
Walsh MC, Wilson-Costello D, Zadell A, Newman N, Fanaroff A. Safety, reliability, and validity of a physiologic definition of bronchopulmonary dysplasia. J Perinatol. 2003;23:451–6.
Balfour-Lynn I, Field D, Gringras P, Hicks B, Jardine E, Jones R, et al. BTS guidelines for home oxygen in children. Thorax. 2009;64:ii1–ii26.
Feltman D, Du H, Leuthner S. Survey of neonatologists’ attitudes toward limiting life-sustaining treatments in the neonatal intensive care unit. J Perinatol. 2012;32:886–92.
Amin RS, Rutter MJ. Airway disease and management in bronchopulmonary dysplasia. Clin Perinatol. 2015;42:857–70.
SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network, Finer NN, Carlo WA, Walsh MC, Rich W, Gantz MG et al. Early CPAP versus surfactant in extremely preterm infants. N Engl J Med. 2010;2010:1970–9..
Schmidt B, Whyte RK, Asztalos EV, Moddemann D, Poets C, Rabi Y, et al. Effects of targeting higher vs lower arterial oxygen saturations on death or disability in extremely preterm infants: a randomized clinical trial. Jama. 2013;309:2111–20.
Subramaniam P, Ho JJ, Davis PG Prophylactic nasal continuous positive airway pressure for preventing morbidity and mortality in very preterm infants. Cochrane Database Syst Rev. 2016;CD001243.
Hines D, Modi N, Lee SK, Isayama T, Sjors G, Gagliardi L, et al. Scoping review shows wide variation in the definitions of bronchopulmonary dysplasia in preterm infants and calls for a consensus. Acta Paediatr. 2017;106:366–74.
Stenmark KR, Abman SH. Lung vascular development: implications for the pathogenesis of bronchopulmonary dysplasia. Annu Rev Physiol. 2005;67:623–61.
Mourani PM, Abman SH. Pulmonary hypertension and vascular abnormalities in bronchopulmonary dysplasia. Clin Perinatol. 2015;42:839–55.
Krishnan U, Feinstein JA, Adatia I, Austin ED, Mullen MP, Hopper RK, et al. Evaluation and management of pulmonary hypertension in children with bronchopulmonary dysplasia. J Pediatr. 2017;188:24–34.e1.
Lauer R, Vadi M, Mason L. Anaesthetic management of the child with co-existing pulmonary disease. Br J Anaesth. 2012;109:i47–i59.
Friesen RH, Williams GD. Anesthetic management of children with pulmonary arterial hypertension. Paediatr Anaesth. 2008;18:208–16.
Carmosino MJ, Friesen RH, Doran A, Ivy DD. Perioperative complications in children with pulmonary hypertension undergoing noncardiac surgery or cardiac catheterization. Anesth Analg. 2007;104:521–7.
Taylor C, Derrick G, McEwan A, Haworth S, Sury M. Risk of cardiac catheterization under anaesthesia in children with pulmonary hypertension. Br J Anaesth. 2007;98:657–61.
Author information
Authors and Affiliations
Contributions
GA is the author that wrote the first draft.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Altit, G., Lee, H.C., Hintz, S. et al. Practices surrounding pulmonary hypertension and bronchopulmonary dysplasia amongst neonatologists caring for premature infants. J Perinatol 38, 361–367 (2018). https://doi.org/10.1038/s41372-017-0025-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41372-017-0025-3
This article is cited by
-
Role of functional echocardiographic parameters in the diagnosis of bronchopulmonary dysplasia-associated pulmonary hypertension
Journal of Perinatology (2022)
-
Screening Echocardiography Identifies Risk Factors for Pulmonary Hypertension at Discharge in Premature Infants with Bronchopulmonary Dysplasia
Pediatric Cardiology (2022)
-
Utility of echocardiography in predicting mortality in infants with severe bronchopulmonary dysplasia
Journal of Perinatology (2020)
-
Factors influencing decision making in neonatology: inhaled nitric oxide in preterm infants
Journal of Perinatology (2019)
-
Agreement of an echocardiogram-based diagnosis of pulmonary hypertension in infants at risk for bronchopulmonary dysplasia among masked reviewers
Journal of Perinatology (2019)